Delivery Order SPE2DB24D2101-SPE2DB25FKPHX
Award Date 9/9/25
Potential Completion Date 9/30/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Lynparza 100 mg tablets (120 count) with a ceiling value of $21,039.24. This firm fixed-price delivery order, which must be completed by July 17, 2025, represents a non-competitive, competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of LYNPARZA 150 mg tablets in quantities of 60 units. This delivery order, valued at $10,499.34 under a firm fixed-price contract type, represents a non-competitive procurement and is scheduled for completion by October 7, 2025. The award was issued to AmerisourceBergen's Corporate Office division, with performance occurring at the company's facility in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a Delivery Order valued at $10,567.60 by the Defense Logistics Agency (DLA) for the supply of LYNPARZA 150 mg tablets (120-count units). The contract is a firm fixed-price, non-set-aside award with a completion date of August 21, 2025, and was issued on July 31, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,543.70 by the Defense Logistics Agency on September 11, 2025, with completion expected by October 2, 2025. The contract calls for the supply of Lynparza 100 mg tablets in quantities of 60 units, a targeted oncology medication used in cancer treatment. The award was made on a firm fixed-price basis without set-aside designation, indicating...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of LYNPARZA 150 mg tablets in quantities of 60s, with a ceiling value of $10,499.34. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, represents a competitive, non-set-aside award to the prime contractor. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $10,567.60 to AmerisourceBergen Drug Corp for the supply of Lynparza 150 mg tablets (120-count units). The contract was awarded on August 12, 2025, with an ultimate completion date of September 3, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order valued at $52,598.10 for the supply of Lynparza 100 mg tablets (120-count units) on September 4, 2025, with an ultimate completion date of September 25, 2025. The contract carries no set-aside designation and was competitively awarded through the Defense Logistics Agency's Medical Supply Chain, which supports pharmaceutical procurement for military and federal healthcare systems. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $10,567.60 to AmerisourceBergen Drug Corp for LYNPARZA 150 mg tablets (120 count) with an ultimate completion date of September 16, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a $21,135.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of Lynparza 150 mg, a specialty pharmaceutical product. This non-set-aside competitive award, issued on August 13, 2025, with an ultimate completion date of September 4, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $21,039.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lynparza 100 mg tablets (120-count units) with an ultimate completion date of October 6, 2025. This non-set-aside contract was competitively awarded on September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...